Executive Development Programme in Biopharma IP Risk Management
-- ViewingNowThe Executive Development Programme in Biopharma IP Risk Management is a certificate course designed to empower professionals with the essential skills for career advancement in the high-stakes world of biopharma intellectual property (IP). This programme meets the growing industry demand for experts who can navigate the complex landscape of IP risk management, particularly in the context of biopharma.
4,455+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Introduction to Biopharma IP Risk Management: Understanding the basics of intellectual property (IP) in the biopharma industry, including patents, trademarks, and trade secrets. This unit will also cover the unique challenges and risks associated with IP in the biopharma sector.
⢠Patent Law and Regulations: A deep dive into the legal framework surrounding patents, including the requirements for obtaining and enforcing patents. This unit will also cover recent changes and updates in patent law, as well as the impact of international patent treaties on biopharma IP.
⢠IP Search and Analysis: Techniques and best practices for conducting IP searches and analyzing the results. This unit will cover both manual and automated search methods, as well as the use of IP databases and search tools.
⢠IP Portfolio Management: Strategies for managing and maintaining a biopharma company's IP portfolio, including the development of an IP strategy, the management of patent applications and grants, and the monitoring of competitors' IP activities.
⢠IP Due Diligence: The process of evaluating the IP assets of a biopharma company, including the identification of potential risks and the assessment of the company's IP strengths and weaknesses. This unit will also cover the role of IP due diligence in mergers and acquisitions, licensing agreements, and other business transactions.
⢠IP Licensing and Commercialization: The legal and business aspects of licensing biopharma IP, including the negotiation and drafting of licensing agreements, the management of licensing relationships, and the commercialization of IP assets. This unit will also cover the use of IP licensing as a revenue generation strategy.
⢠IP Litigation and Dispute Resolution: Strategies for resolving IP disputes, including the use of alternative dispute resolution methods, such as mediation and arbitration. This unit will also cover the litigation process, including the selection of legal counsel, the development of a litigation strategy, and the management of litigation
ę˛˝ë Ľ 경ëĄ
ę˛˝ë Ľ ę˛˝ëĄ ěěą ě¤...
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
